Zydus receives final approval from the USFDA for Carboplatin Injection

Zydus receives final approval from the USFDA for Carboplatin Injection Ahmedabad, 01 April 2016 Zydus Cadila has received the final approval from the USFDA to market Carboplatin Injection, 10 mg/ml in 5 ml, 15 ml and 45 ml. The group now ha s more than 100 approvals and has so far filed over 280 ANDAs since the commencement of the filing process in FY 2003-04. ***

The release as fetched from its publisher. zyduslife.com ↗